TEL:400-188-1552 800-880-1552
Login / Sign up
HOME
ABOUT
Company Profile
Corporate Structure
Qualification & Honor
Corporate Culture
NEWS
Dynamic
Notice
PRODUCTS
Biologics
Small-Molecule Drugs
APIs
Intermediates
Customer Service
H&R
Talent Concept
Recruitment Information
Employee Growth
Human Resources
MEMBER
Member Login
Communication
CONTACT
Craftsmanship Alchemy: Taming the "Twin" Impurities in Orforglipron
2026-01-16
Hiteck Biopharmaceutical National Class 1 Innovative Drug Selected as a “61020” Landmark Innovation Achievement of Hubei Province
2026-01-06
Congratulations to Professor Liu Wenbo on publishing significant research findings in《Nature Communications》
2026-01-05
ASH 2025 | Real-World Data on Injectable Aponermin Presented at ASH 2025
2025-12-26
Hiteck Publishes Phase I Clinical Study Results of HT006.2.2 in EJPS
2025-12-24
